WHO ICTRP trial

A Phase III trial to assess the efficacy and safety of Boswellia serrata cream…

CTRI/2013/09/004030 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2013/09/004030
Public title A Phase III trial to assess the efficacy and safety of Boswellia serrata cream in Psoriasis
Scientific title An open multicentric Phase III clinical trial to investigate the efficacy and safety of Boswellia serrata cream - A formulation for the management of Psoriasis.
Primary sponsor Sami labs Limited
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3
Countries India
Conditions Health Condition 1: null- Subjects with mild to moderate Psoriasis
Interventions Intervention1: Boswellia serrata cream: Cream to be applied topically thrice a day for 12 weeks Intervention2: Boswellia serrata cream: To be applied topically three times daily Intervention3: Boswellia serrata cream: To be applied…
Registration date Sep 30, 2013
Target size 200
Secondary IDs CPMS 01/APR/06/MUM
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations